Stock Scorecard



Stock Summary for Staar Surgical Company (STAA) - $46.89 as of 4/26/2024 3:48:54 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for STAA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for STAA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for STAA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for STAA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for STAA

Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating 4/25/2024 7:43:00 PM
Staar Surgical Shows Market Leadership With Jump To 84 RS Rating 4/25/2024 7:00:00 AM
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday - Apple ( NASDAQ:AAPL ) 4/11/2024 12:31:00 PM
Stocks To Watch: Staar Surgical Sees RS Rating Rise To 87 4/8/2024 7:00:00 AM
Strength Seen in Staar Surgical ( STAA ) : Can Its 16.5% Jump Turn into More Strength? 4/5/2024 1:15:00 PM
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus - Staar Surgical ( NASDAQ:STAA ) 4/4/2024 5:54:00 PM
Medtech Bounds Off 200-Day Line After Crushing Quarterly Views 4/4/2024 1:52:00 PM
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses 3/20/2024 8:22:00 AM
Strength Seen in West Pharmaceutical ( WST ) : Can Its 5.7% Jump Turn into More Strength? 3/13/2024 10:57:00 AM
Netflix To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday - Netflix ( NASDAQ:NFLX ) 3/11/2024 12:16:00 PM

Financial Details for STAA

Company Overview

Ticker STAA
Company Name Staar Surgical Company
Country USA
Description STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company is headquartered in Lake Forest, California.
Sector Name LIFE SCIENCES
Industry Name OPHTHALMIC GOODS
Most Recent Quarter 1/31/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 46.89
Last Day Price Updated 4/26/2024 3:48:54 PM EST
Last Day Volume 0
Average Daily Volume 752,238
52-Week High 73.13
52-Week Low 26.66
Last Price to 52 Week Low 75.88%

Valuation Measures

Trailing PE 109.21
Industry PE 70.40
Sector PE 56.64
5-Year Average PE 114.02
Free Cash Flow Ratio 10.44
Industry Free Cash Flow Ratio 59.39
Sector Free Cash Flow Ratio 30.65
Current Ratio Most Recent Quarter 5.62
Total Cash Per Share 4.49
Book Value Per Share Most Recent Quarter 7.91
Price to Book Ratio 6.30
Industry Price to Book Ratio 3.55
Sector Price to Book Ratio 22.15
Price to Sales Ratio Twelve Trailing Months 7.55
Industry Price to Sales Ratio Twelve Trailing Months 5.62
Sector Price to Sales Ratio Twelve Trailing Months 5.17

Share Statistics

Total Shares Outstanding 49,131,100
Market Capitalization 2,303,757,279
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 1.88%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 22.10%
Annual Earnings Growth -46.18%
Reported EPS 12 Trailing Months 0.43
Reported EPS Past Year 0.60
Reported EPS Prior Year 0.78
Net Income Twelve Trailing Months 21,347,000
Net Income Past Year 21,347,000
Net Income Prior Year 39,665,000
Quarterly Revenue Growth YOY 19.10%
5-Year Revenue Growth 21.07%

Balance Sheet

Total Cash Most Recent Quarter 220,726,000
Total Cash Past Year 220,726,000
Total Cash Prior Year 211,639,000
Net Cash Position Most Recent Quarter 219,444,000
Net Cash Position Past Year 219,347,000
Long Term Debt Past Year 1,379,000
Long Term Debt Prior Year 1,379,000
Total Debt Most Recent Quarter 1,282,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 385,954,000
Total Stockholder Equity Prior Year 336,112,000
Total Stockholder Equity Most Recent Quarter 385,954,000

Options

Put/Call Ratio 0.40
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 2.39
MACD Signal 2.88
20-Day Bollinger Lower Band 21.58
20-Day Bollinger Middle Band 35.42
20-Day Bollinger Upper Band 49.25
Beta 0.88
RSI 58.93
50-Day SMA 41.62
200-Day SMA 75.09

System

Modified 4/27/2024 12:08:43 PM EST